日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo

多哥中部地区接受伊维菌素治疗 30 年且暴露于寄生虫传播的盘尾丝虫病患者的盘尾丝虫特异性抗体和细胞反应

Saskia I Johanns, Richard G Gantin, Bawoubadi Wangala, Kossi Komlan, Wemboo A Halatoko, Meba Banla, Potchoziou Karabou, Adrian Jf Luty, Hartwig Schulz-Key, Carsten Köhler, Peter T Soboslay

Of mice, cattle, and humans: the immunology and treatment of river blindness

从老鼠、牛到人类:河盲症的免疫学和治疗

Allen, Judith E; Adjei, Ohene; Bain, Odile; Hoerauf, Achim; Hoffmann, Wolfgang H; Makepeace, Benjamin L; Schulz-Key, Hartwig; Tanya, Vincent N; Trees, Alexander J; Wanji, Samuel; Taylor, David W

Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy

接受伊维菌素重复治疗16年后,盘尾丝虫病患者体内盘尾丝虫特异性抗体和细胞因子反应

Mai, C S; Hamm, D M; Banla, M; Agossou, A; Schulz-Key, H; Heuschkel, C; Soboslay, P T

Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients.

多房棘球绦虫囊蚴可调节肺泡棘球蚴病患者外周血单核细胞的细胞因子和趋化因子释放

Hübner M P, Manfras B J, Margos M C, Eiffler D, Hoffmann W H, Schulz-Key H, Kern P, Soboslay P T

Chemokines in onchocerciasis patients after a single dose of ivermectin.

单次服用伊维菌素后,盘尾丝虫病患者的趋化因子

Fendt J, Hamm D M, Banla M, Schulz-Key H, Wolf H, Helling-Giese G, Heuschkel C, Soboslay P T

Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers

产前免疫启动对感染盘尾丝虫病的母婴新生儿特异性细胞反应和细胞因子产生的影响

Soboslay, P T; Geiger, S M; Drabner, B; Banla, M; Batchassi, E; Kowu, L A; Stadler, A; Schulz-Key, H

Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease

盘尾丝虫病中的免疫调节:在无微丝蚴病和临床症状的暴露个体中,对盘尾丝虫低分子量抗原的Th1型反应占主导地位

Lüder, C G; Schulz-Key, H; Banla, M; Pritze, S; Soboslay, P T

Characterization of an immunodominant Onchocerca volvulus antigen with patient sera and a monoclonal antibody

利用患者血清和单克隆抗体对免疫优势性盘尾丝虫抗原进行表征

Lucius, R; Schulz-Key, H; Büttner, D W; Kern, A; Kaltmann, B; Prod'hon, J; Seeber, F; Walter, R D; Saxena, K C; Diesfeld, H J

Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis

一项双盲研究比较了伊维菌素、乙胺嗪和安慰剂治疗盘尾丝虫病的眼部表现。

Dadzie, K Y; Bird, A C; Awadzi, K; Schulz-Key, H; Gilles, H M; Aziz, M A